retatrutide clinical trial saudi arabia New Phase 3 data just dropped 👀 Eli Lilly's reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats Pharmacologic Disruption: How Emerging Weight

Cut Back on Refined Carbohydrates Refined carbs like white bread, pasta, and baked goods digest quickly and may lead to sharper postmeal blood sugar spikes, says Nassar

Quality, dose, formulation, and sourcing can vary significantly, and compounded versions are not subject to the same regulatory oversight as approved drugs

Among them, weight loss was the most in the double treatment

PMID 11502823

Compared with conventional GLP-1 receptor agonists, such as liraglutide and semaglutide, tirzepatide has demonstrated superior efficacy in body weight control in several phase III clinical trials, with average weight reductions exceeding 20% in some study populations (15)